SCHEMBL22999514

SCHEMBL22999514

O=C(Cl)c1cc2nn[nH]c2cc1F

nearest known ligand 0.35

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.35
▸ ALOX15 P16050 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16962998 0.85 KDM4E (0.40) ALDH1A1
SCHEMBL30807502 0.85 KDM4E (0.40) ALDH1A1
SCHEMBL16961607 0.80 MAPK1 (0.41) ALDH1A1
SCHEMBL30807491 0.80 MAPK1 (0.41) ALDH1A1
SCHEMBL18983913 0.78 KDM4E (0.40) ALDH1A1
SCHEMBL11692364 0.76 ALPL (0.33) ALDH1A1
SCHEMBL102964 0.76 KDM4E (0.35) ALDH1A1
SCHEMBL8568181 0.73 MAPT (0.52) ALDH1A1
SCHEMBL2831954 0.73 HCAR2 (0.32) ALDH1A1ALOX15
SCHEMBL5685114 0.72 SMN1; SMN2 (0.36) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021032323-A1 FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES GALAPAGOS NV (BE) 2021-02-25 — — WO disclosed
EP-3782997-A1 FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES Galapagos N.V. (BE) 2021-02-24 — — EP disclosed
EP-3782997-A1 FUSED PYRIMIDINE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF FIBROTIC DISEASES Galapagos N.V. (BE) 2021-02-24 — — EP disclosed
Send feedback